HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Pierre-Régis Burgel Selected Research
Pierre-Régis Burgel Research Topics
Disease
48
Cystic Fibrosis (Mucoviscidosis)
05/2024 - 05/2005
24
Chronic Obstructive Pulmonary Disease (COPD)
01/2024 - 04/2014
11
Lung Diseases (Lung Disease)
04/2024 - 01/2017
10
Infections
05/2024 - 06/2013
6
Inflammation (Inflammations)
03/2023 - 10/2008
5
Bronchiectasis
02/2024 - 05/2015
5
Asthma (Bronchial Asthma)
02/2024 - 01/2017
4
Peritonitis
01/2023 - 01/2016
3
Pneumonia (Pneumonitis)
01/2023 - 01/2020
3
Sepsis (Septicemia)
01/2023 - 05/2015
3
COVID-19
01/2023 - 01/2022
3
Allergic Bronchopulmonary Aspergillosis
01/2022 - 02/2012
3
Hypoxia (Hypoxemia)
11/2021 - 01/2005
2
Persistent Infection
05/2024 - 01/2020
2
Disease Progression
01/2024 - 01/2022
2
Pulmonary Hypertension
10/2023 - 11/2021
2
Inborn Genetic Diseases (Disease, Hereditary)
07/2023 - 01/2023
2
Cough
08/2022 - 01/2017
2
Respiratory Insufficiency (Respiratory Failure)
01/2022 - 03/2016
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018 - 07/2012
2
Dyspnea (Shortness of Breath)
01/2018 - 01/2017
2
Hemoptysis
03/2016 - 03/2016
1
Interstitial Lung Diseases (Interstitial Lung Disease)
10/2023
1
Bacterial Infections (Bacterial Infection)
03/2023
1
Acne Vulgaris
01/2023
1
Hepatitis
01/2023
1
Acneiform Eruptions
01/2023
1
Bacterial Pneumonia
01/2023
1
Acute Lung Injury
01/2023
1
Respiratory Tract Diseases (Respiratory Tract Disease)
06/2022
1
Bronchial Diseases
11/2021
1
Chronic Bronchitis
01/2021
1
Reinfection
10/2020
1
Malnutrition (Nutritional Deficiencies)
01/2020
1
Eosinophilia
01/2020
1
Clinical Deterioration
01/2020
1
Neoplasms (Cancer)
10/2018
Drug/Important Bio-Agent (IBA)
10
ivacaftor drug combination tezacaftor
IBA
04/2024 - 01/2021
10
elexacaftor
IBA
04/2024 - 01/2021
10
Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)
IBA
07/2023 - 12/2013
8
Anti-Bacterial Agents (Antibiotics)
IBA
05/2024 - 12/2011
8
Adrenal Cortex Hormones (Corticosteroids)
IBA
02/2024 - 04/2014
7
ivacaftor
IBA
03/2023 - 01/2016
6
Biomarkers (Surrogate Marker)
IBA
01/2023 - 12/2014
5
lumacaftor
IBA
03/2023 - 05/2017
4
Bronchodilator Agents (Bronchodilators)
IBA
08/2022 - 01/2017
3
RNA (Ribonucleic Acid)
IBA
01/2023 - 12/2013
3
Gold
IBA
01/2021 - 04/2014
2
Embarc
IBA
02/2024 - 01/2024
2
Zanamivir (Relenza)
FDA Link
01/2023 - 10/2022
2
Oseltamivir (Tamiflu)
FDA Link
01/2023 - 10/2022
2
Proteins (Proteins, Gene)
FDA Link
01/2023 - 10/2008
2
Neuraminidase (Sialidase)
IBA
01/2023 - 10/2022
2
Environmental Pollutants (Pollutants, Environmental)
IBA
08/2022 - 06/2013
2
Oxygen (Dioxygen)
IBA
01/2022 - 01/2020
2
Itraconazole (Sporanox)
FDA Link
Generic
01/2022 - 02/2012
2
Interleukin-17 (Interleukin 17)
IBA
10/2020 - 08/2011
2
Mucins
IBA
10/2018 - 02/2007
2
Azoles
IBA
01/2016 - 02/2012
2
Proliferating Cell Nuclear Antigen (PCNA)
IBA
01/2016 - 01/2012
2
ErbB Receptors (EGF Receptor)
IBA
12/2013 - 10/2008
1
insulin receptor-related receptor (IRR)
IBA
01/2024
1
Vaccines
IBA
01/2024
1
Nonsense Codon (Nonsense Mutation)
IBA
11/2023
1
prednylidene (Pred)
IBA
10/2023
1
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
03/2023
1
tezacaftor
IBA
01/2023
1
Glucose (Dextrose)
FDA Link
Generic
01/2023
1
Lipopolysaccharides
IBA
01/2023
1
Sialic Acids
IBA
01/2023
1
Isotretinoin (Accutane)
FDA Link
Generic
01/2023
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2023
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
10/2022
1
Indicators and Reagents (Reagents)
IBA
08/2022
1
Prednisolone (Predate)
FDA Link
Generic
01/2022
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
11/2021
1
Monocrotaline
IBA
11/2021
1
trans-crotonin (CTN)
IBA
11/2021
1
COVID-19 Vaccines
IBA
01/2021
1
Gases
IBA
01/2021
1
ensifentrine
IBA
01/2021
1
Roflumilast
IBA
01/2021
1
Phosphodiesterase 4 Inhibitors
IBA
01/2021
1
Phosphoric Diester Hydrolases (Phosphodiesterases)
IBA
01/2021
1
Immunoglobulin A (IgA)
IBA
10/2020
1
Secretory Immunoglobulin A (SIgA)
IBA
10/2020
1
Expectorants (Mucolytics)
IBA
01/2020
1
Enzymes
IBA
01/2020
1
Cholinergic Agents (Cholinergics)
IBA
01/2020
1
Cholinergic Antagonists (Anticholinergics)
IBA
08/2019
1
Nivolumab
IBA
10/2018
Therapy/Procedure
15
Therapeutics
05/2024 - 06/2014
9
Lung Transplantation
03/2024 - 12/2011
6
Transplantation
01/2024 - 02/2007
2
Artificial Respiration (Mechanical Ventilation)
01/2020 - 01/2005
2
Noninvasive Ventilation
01/2020 - 11/2008
1
Ligation
01/2023
1
Punctures
01/2023
1
Critical Care (Surgical Intensive Care)
11/2020
1
High-Protein Diet
01/2020